2 Reasons Why GE HealthCare Stock Is Climbing After Earnings — Barrons.com

What happened

GE HealthCare reported quarterly revenue of $5.51 billion, up 7.2% and above Wall Street's $5.35 billion estimate. Adjusted earnings of $1.34 a share beat expectations of $1.20. The company raised its full-year guidance.

Confirmed

Global impact / market context

Beating forecasts and raising guidance signals stronger demand for its medical devices, which can lift future revenue and profit. Investors may see the results as easing concerns about the company lagging its former General Electric siblings.

Analyst inference

GE HealthCare shares had fallen 13% this year before Wednesday, hurt by macroeconomic headwinds, supply chain costs, and competition from local manufacturers in China. The stock has trailed GE Vernova and GE Aerospace since the 2024 three-way split of General Electric.

Analyst inference

What to watch

1. Management now targets 4% organic revenue growth for the year, which means growth excluding currency swings and deals, up from the prior 3% to 4% range. Confirmed
2. The company sees adjusted earnings per share of $4.95 to $5.05 for the full year, compared with a prior range of $4.80 to $5. Confirmed
3. Watch whether improvement across all business segments holds, and whether Chinese competition and supply chain costs keep pressuring profit per sale and future guidance. Analyst inference

Evidence

• Original source link unavailable